Cultured AFB Antitubercular DST Rapid 4 Drugs Panel Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Rapid 4 Drugs Panel Test represents a critical advancement in tuberculosis management and treatment optimization. This sophisticated diagnostic procedure evaluates the sensitivity of Mycobacterium tuberculosis complex to four essential first-line antitubercular medications, providing healthcare providers with vital information to design effective treatment regimens for patients battling tuberculosis.
What This Test Measures and Detects
This specialized panel test specifically assesses the drug susceptibility of Mycobacterium tuberculosis complex isolates to four cornerstone tuberculosis medications:
- Streptomycin – An aminoglycoside antibiotic crucial for TB treatment
- Isoniazid – A first-line bactericidal agent against Mycobacterium tuberculosis
- Rifampicin – A key rifamycin antibiotic essential for TB eradication
- Ethambutol – An important bacteriostatic agent in combination therapy
The test utilizes automated fluorescent technology to rapidly determine whether the tuberculosis bacteria are susceptible or resistant to these critical medications, enabling precise treatment planning and preventing therapeutic failures.
Who Should Consider This Test
This drug sensitivity panel is particularly important for individuals experiencing:
- Persistent cough lasting more than three weeks
- Unexplained weight loss and night sweats
- Previous tuberculosis treatment failure
- Relapse of tuberculosis symptoms after completed treatment
- Exposure to drug-resistant tuberculosis cases
- Immune-compromised conditions increasing TB susceptibility
- Travel history to regions with high drug-resistant TB prevalence
Key Benefits of Taking This Test
- Personalized Treatment Planning: Enables customized TB therapy based on individual bacterial sensitivity patterns
- Prevention of Treatment Failure: Identifies drug resistance early to avoid ineffective medication regimens
- Reduced Transmission Risk: Helps control drug-resistant TB spread through appropriate treatment
- Cost-Effective Care: Prevents unnecessary medication expenses and hospitalizations
- Improved Patient Outcomes: Increases treatment success rates through targeted therapy
- Public Health Protection: Contributes to community TB control efforts
Understanding Your Test Results
Your test results will provide clear guidance on the sensitivity of your Mycobacterium tuberculosis isolate to each of the four tested medications:
Susceptible Results
If the bacteria show susceptibility to all four medications, this indicates that standard first-line TB treatment should be effective. Your physician can proceed with confidence using conventional therapy protocols.
Resistant Results
Resistance to one or more medications requires immediate adjustment of your treatment plan. Your healthcare provider will:
- Discontinue ineffective medications
- Incorporate alternative second-line drugs
- Extend treatment duration as necessary
- Implement enhanced monitoring protocols
Mixed Resistance Patterns
Some isolates may show varying resistance patterns across different drugs. In such cases, your physician will design a customized regimen using the medications to which your bacteria remain sensitive, potentially combining first-line and second-line agents.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $162 |
| Regular Price | $226 |
Nationwide Testing Availability
We proudly offer the Cultured AFB Antitubercular DST Rapid 4 Drugs Panel Test at our state-of-the-art facilities across the United States. Our network includes testing centers in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Each location maintains the same high standards of laboratory excellence and patient care.
Sample Collection and Processing
This test requires submission of pure growth of Mycobacterium tuberculosis complex on appropriate media in a sterile screw-capped container, shipped refrigerated in a sealed plastic bag. Alternatively, when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in our laboratory from previously submitted specimens will be processed for antitubercular sensitivity analysis.
Turnaround Time: Samples accepted daily by 3:30 PM | Reports available within 21 days
Take Control of Your Tuberculosis Treatment Today
Don’t leave your tuberculosis treatment to chance. The Cultured AFB Antitubercular DST Rapid 4 Drugs Panel Test provides the critical information needed to ensure your treatment is effective and targeted. With drug-resistant tuberculosis becoming increasingly common, this test offers peace of mind and scientific certainty in your therapeutic approach.
Ready to schedule your test? Contact us now at +1(267) 388-9828 to book your appointment or speak with our tuberculosis specialists. Our team is available to answer your questions and guide you through the testing process.
Take the first step toward personalized, effective tuberculosis treatment. Call today and discover how our advanced drug sensitivity testing can optimize your healthcare outcomes.
